Postmarket Safety Managers Begin Oversight Roles In Drug Review Divisions
Executive Summary
Associate directors for safety and safety-regulatory program managers have begun their postmarket drug safety oversight roles within FDA's Office of New Drugs' 17 drug review divisions
You may also be interested in...
Drug Safety’s “Equal Voice” To Be Considered At Internal CDER Workshop
Review staff from the Center for Drug Evaluation and Research will meet in December to discuss how to implement the concept of giving an "equal voice" to safety personnel during regulatory decision-making
Drug Safety’s “Equal Voice” To Be Considered At Internal CDER Workshop
Review staff from the Center for Drug Evaluation and Research will meet in December to discuss how to implement the concept of giving an "equal voice" to safety personnel during regulatory decision-making
Safety First: FDA Unveils New Postmarketing Management Process For Safety
With FDA's latest new initiatives to address problems with postmarketing safety processes -Safety First/Safe Use - the agency is aiming at applying PDUFA-style management to postmarketing drug safety issues